查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198592

远程超声系统市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Teleultrasound System Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 117 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，远程超声诊断系统市场预计将以 6% 的复合年增长率增长。

主要亮点

  • COVID-19 的出现对市场的增长产生了重大影响。 在大流行初期，视频问诊开始流行，以减少就诊次数并避免感染风险。 由于其在疾病诊断中的先进应用，望远镜超声 (TUS) 在此期间获得了普及。
  • 根据 2022 年 6 月发表在《医学与生物学超声杂誌》上的一篇论文，超声在急诊分诊中发挥着重要作用，有助于降低孕妇、儿童等特定患者群体感染 COVID-19 的风险，和行动不便的患者。19 在识别肺炎方面提供了明显的优势。 因此，TUS 获得了需求，并且 TUS 的应用随着时间的推移而增加。
  • 由于 TUS 是一种先进技术，其诊断准确性和图像质量可与常规超声相媲美，根据上述消息来源，在 COVID-19 期间需要提高远程医疗 (TH) 能力。这被视为一个问题当然。 因此，大流行对所研究的市场产生了相当积极的影响，预计在预测期内将保持其强大的主导地位。
  • 在预测期内，先进诊断技术的引入、目标疾病患病率的增加以及老年人口的增加等因素预计将促进市场增长。
  • 研究目标市场的增长归因于癌症和心血管疾病等目标疾病的患病率上升。 例如，根据英国心臟基金会（BHF）2022年8月发布的《英国概况》，全国约有760万人患有心臟和循环系统疾病，男性约400万，女性约400万。约360万人们。 心臟和循环系统疾病的患病率非常高，推动了对新诊断方案的需求。 由于近年来远程医疗的盛行，疾病的爆发有望为在研市场带来新的机遇，加速市场扩张。
  • 此外，技术先进产品的兴起和主要参与者的其他战略活动也在推动所研究的市场。 例如，2022年3月，GE Healthcare向Pulsenmore Ltd战略投资5000万美元，通过Pulsenmore与智能手机对接的手持式TUS设备进军家庭护理领域，让女性在家中自主扫描超声波，获得及时的医疗临床反馈。专业人员。 预计此类新兴市场的发展将在预测期内推动市场增长。
  • 但是，缺乏熟练的专业人员以及对数据安全和隐私的担忧可能会阻碍预测期内的市场增长。

远程超声系统市场趋势

实时远程超声诊断细分市场有望稳步增长

  • 实时超声系统是实用系统，因为它们支持同步（实时）远程超声检查。 因此，实时 TUS 系统有望得到积极扩展。
  • 如 2021 年 8 月发表在《超声心动图杂誌》上的一篇论文所示，可以共享屏幕并与远程医生实时交流的新型超声诊断设备的出现最近获得了需求。 它为无法执行常规超声的医生提供了一个独特的机会，可以通过使用实时 TUS 在实时咨询中提供专家建议。
  • 此外，如上述来源所述，研究人员发现使用支持 TUS 的新型便携式平板电脑超声系统时超声心动图结果有所改善。 由于此类情况，对实时 TUS 的需求正在增加，预计未来会进一步增长。
  • 此外，远程实时监控系统的开发可以为急救医务人员提供院前急救超声诊断支持。 例如，飞利浦超声系统 EPIQ 和 Affiniti Collaboration Live 使临床医生能够与同事实时协作，随时随地完成图像采集和诊断。 这些先进的技术和功能有望推动该细分市场的增长。 因此，上述因素表明实时 TUS 的采用越来越多，预计将在预测期内推动细分市场的增长。

北美占据了很大的市场份额，预计在预测期内也会如此

  • 北美在所研究的市场中占有很大份额，预计在预测期内仍将是其据点。 这背后的主要因素是癌症和心脏病等慢性病的增加、老年人口的增加以及具有先进技术的产品的普及。
  • 作为远程医疗领域，TUS 有可能解决缺乏高质量超声检查（包括乳腺超声筛查）医疗资源的问题。 对于没有超声诊断经验的医生进行癌症筛查也很有用。 市场增长的主要驱动力是北美国家不断增加的癌症发病率。 例如，根据美国癌症协会 (ACS) 发布的《2022 年癌症事实与数据》，2022 年美国将可能诊断出约 190 万例新癌症病例。
  • 根据国家癌症研究所 (NCI) 2022 年更新，乳腺癌是最常见的癌症。 根据上述来源，估计 2022 年美国将有 290,560 例乳腺癌新病例。 前列腺癌和肺癌是下一个最常见的癌症。 由于这种癌症负担，预计与癌症相关的筛查将会增加。 预计这将进一步增加对 TUS 系统的需求，并在预测期内推动市场增长。
  • 此外，预计该地区多家医院和诊所采用 TUS 系统也将有助于市场增长。 例如，2022 年 5 月，Jefferson Radiology 推出了用于超声预约的高级远程医疗软件。 Collaboration Live 是 Philips(TM) 的 TUS 软件，它使放射科医生能够虚拟地实时连接患者，从而显着改善患者的就诊。 因此，预计此类案例将有助于该地区的市场增长。
  • 因此，预计北美在癌症筛查中采用 TUS 将在预测期内推动市场增长。

远程超声系统市场竞争对手分析

远程超声系统市场竞争激烈，由多家大型企业组成。 从市场份额的角度来看，一些主要参与者主导着市场。 目前主导市场的公司包括 Koninklijke Philips N.V、Remote Medical Technologies, LLC、Robo Medical、AdEchoTech、T-MedRobotics 和 Pulsenmore Ltd。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动力
    • 先进诊断技术简介
    • 目标疾病的流行率增加
    • 老年人口增加
  • 市场製约因素
    • 缺乏熟练的专业人员
    • 缺乏数据安全和隐私问题
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按类型
    • 常规远程超声诊断
    • 实时远程诊断成像
  • 最终用户
    • 医院和诊所
    • 门诊手术中心
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Koninklijke Philips N.V.
    • Remote Medical Technologies, LLC
    • Robo Medical
    • AdEchoTech
    • T-MedRobotics
    • Analogic Corporation
    • AMD Global Telemedicine
    • ONRAD, Inc.
    • Ram Soft, Inc.
    • Medica Group PLC.
    • Pulsenmore Ltd.
    • BMV Medtech Group Co., Ltd.

第7章 市场机会与今后动向

简介目录
Product Code: 68873

The teleultrasound system market is expected to register a CAGR of 6% during the forecast period.

Key Highlights

  • The emergence of COVID-19 significantly impacted the market growth. During the initial phase of the pandemic, video consultations became more popular to reduce the number of hospital visits and avoid the risk of infection. Teleultrasound (TUS) gained traction during that time due to its advanced application for disease diagnosis.
  • As per an article published in June 2022 in the Journal of Ultrasound in Medicine and Biology, ultrasound played a crucial role in emergency triage and provided clear benefits in identifying COVID-19 pneumonia for specific patient populations, including expectant mothers, children, and immobile patients. Hence, the TUS gained demand, and the application of TUS increased over time.
  • As per the source above, TUS was incorporated as an obvious step to improve the capabilities of telehealth (TH) during the COVID-19 period, as TUS is an advanced technology with diagnostic precision and image quality comparable to regular ultrasound exams. Hence, the pandemic had a considerably positive impact on the studied market and is expected to continue its strong hold over the forecast period.
  • Factors such as the introduction of technologically advanced diagnostics, increasing prevalence of target diseases, and growing geriatric population base are expected to contribute to the market growth over the forecast period.
  • The growth of the studied market is attributed to the increasing prevalence of target diseases such as cancer and cardiovascular diseases. For instance, according to the "UK Factsheet" published by the British Heart Foundation (BHF) in August 2022, there are around 7.6 million people in the country who suffer from heart and circulatory disorders, with almost 4 million men and 3.6 million women. Patients with heart and circulatory diseases, which are extremely common, drive demand for new diagnostic options. As telehealth has grown in popularity in recent years, it is projected that the incidence of diseases will open up new opportunities for the market under study and accelerate market expansion.
  • Moreover, the increasing availability of technologically advanced products and other strategic activities by the major players is also boosting the market studied. For instance, in March 2022, GE Healthcare strategically invested USD 50 million in Pulsenmore Ltd and entered the homecare segment through Pulsenmore's handheld TUS device that docks with a smartphone, allowing women to perform ultrasound self-scans at home and receive fast clinical feedback from healthcare professionals. Such developments are anticipated to drive market growth during the forecast period.
  • However, the lack of skilled professionals and data security and privacy concerns are likely to hamper the market growth over the forecast period.

Teleultrasound System Market Trends

Real-Time Teleultrasound​ Segment is Expected to Witness a Healthy Growth

  • Real-time ultrasound systems are practical because they enable synchronous (real-time) remote ultrasonographic tests. Thus, it is anticipated that the real-time TUS system will expand positively.
  • As per an article published in August 2021 in the Journal of Echocardiography, the emergence of a novel ultrasound device that enables real-time screen sharing and telecommunication with remote doctors has gained demand recently. That provides a unique opportunity for doctors unable to perform the traditional ultrasound to provide expert advice during a real-time consultation by using real-time TUS.
  • In addition, as per the source above, when the study researchers used a novel tablet-based hand-held ultrasound device that enables TUS, it provided improved echocardiography results. Thus, owing to such instances, the real-time TUS is gaining demand and is anticipated to fuel segmental growth.
  • Furthermore, prehospital emergency ultrasonography support for emergency medicine practitioners may be possible with the development of remote real-time supervision. For instance, Philips Ultrasound Systems EPIQ and Affiniti Collaboration Live allow clinicians to collaborate in real-time with colleagues to complete image acquisition and diagnosis regardless of location. These advanced technology and features are expected to drive segmental growth. Therefore, the above factors show an increase in the adoption of real-time TUS, and it is expected to fuel the segment growth over the forecast period.

North America Holds a Significant Share in the Market and Expected to do Same in the Forecast Period

  • North America holds a major market share in the studied market and is anticipated to maintain its stronghold during the forecast period. The growth is majorly attributed to the increase in chronic diseases such as cancer and cardiology, the geriatric population, and the availability of technically advanced products.
  • As a branch of telemedicine, TUS can potentially solve the problem of insufficient medical resources for high-quality ultrasound examinations, including breast ultrasound screening. It can also help physicians without ultrasound experience to perform cancer screenings. The major factor behind the market growth is the increasing burden of cancer in North American countries. For instance, according to the Cancer Facts and Figures 2022 published by the American Cancer Society (ACS), nearly 1.9 million new cancer cases will likely be diagnosed in the United States in 2022.
  • In addition, according to the National Cancer Institute (NCI) 2022 update, breast cancer is the most common cancer. As per the source above, it is estimated that there will be 290,560 new breast cancer cases in the United States in 2022. Prostate cancer and lung cancer are the next most frequent cancers in the country. This burden of cancer is anticipated to increase the screenings related to cancer. This is further expected to increase demand for TUS systems, thereby driving the market growth over the forecast period.
  • Furthermore, the adoption of TUS systems by various hospitals and clinics in the region is expected to contribute to market growth. For instance, in May 2022, Jefferson Radiology implemented advanced telemedicine software for its diagnostic ultrasound appointments. Collaboration Live, a TUS software by Philips™, will dramatically improve patient access by enabling radiologists to connect with patients virtually and in real-time. Thus, such instances are expected to contribute to regional market growth.
  • Hence, the studied market is anticipated to witness growth owing to the TUS adoption in North America's cancer screening during the forecast period.

Teleultrasound System Market Competitor Analysis

The teleultrasound system market is competitive and consists of several major players. In terms of market share, a few major players dominate the market. Some companies currently dominating the market are Koninklijke Philips N.V, Remote Medical Technologies, LLC, Robo Medical, AdEchoTech, T-MedRobotics, and Pulsenmore Ltd., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Introduction of Technologically Advanced Diagnostics
    • 4.2.2 Increasing Prevalence of Target Diseases
    • 4.2.3 Growing Base of Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Professionals
    • 4.3.2 Lack of Data Security and Privacy Concerns
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Traditional teleultrasound
    • 5.1.2 Real-Time Teleultrasound
  • 5.2 By End User
    • 5.2.1 Hospitals and Clinics
    • 5.2.2 Ambulatory Surgical Centers
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Koninklijke Philips N.V.
    • 6.1.2 Remote Medical Technologies, LLC
    • 6.1.3 Robo Medical
    • 6.1.4 AdEchoTech
    • 6.1.5 T-MedRobotics
    • 6.1.6 Analogic Corporation
    • 6.1.7 AMD Global Telemedicine
    • 6.1.8 ONRAD, Inc.
    • 6.1.9 Ram Soft, Inc.
    • 6.1.10 Medica Group PLC.
    • 6.1.11 Pulsenmore Ltd.
    • 6.1.12 BMV Medtech Group Co., Ltd.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS